Skip to main content

Zegerid Santarus, Inc. - Treatment for Heartburn/GERD, Erosive Esophagitis, Duodenal Ulcers

Zegerid is approved for short-term treatment (4-8 wks) of active duodenal ulcer; treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD); short-term treatment (4-8 wks) of erosive esophagitis which has been diagnosed by endoscopy; and maintenance of healing of erosive esophagitis.

Related articles

Zegerid (omeprazole and sodium bicarbonate) FDA Approval History

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.